Identification and validation of new therapeutic targets in pediatric leukemia through an aneuploidy-based synthetic lethality screen |
Dana-Farber Cancer Institute |
I Care I Cure |
A novel mouse model of rhabdomyosarcoma |
Vanderbilt University Medical Center |
I Care I Cure |
Novel STAT3 drug development for childhood osteosarcoma therapy using drug repositioning |
Research Institute at Nationwide Children's Hospital |
Flashes of Hope |
Developing Immune-modulatory Strategies Against Primary and Metastatic Tumors in the Central Nervous System |
Case Western Reserve University |
Flashes of Hope |
Mechanisms of Oncogenic Transformation by TLX1/HOX11 |
University of Michigan |
I Care I Cure |
Targeting polycomb-mediated epigenetic silencing in T cell acute lymphoblastic leukemia |
Vanderbilt University Medical Center |
I Care I Cure |
Phase I and II Clinical Research Program Infrastructure Award |
University of Minnesota |
Northwestern Mutual Foundation |
Development of a Childhood Leukemia Translational Research Program |
Dana-Farber Cancer Institute |
I Care I Cure |
Discovery of Inhibitors of MLL Fusion Proteins as Targeted Therapies for Pediatric Acute Leukemia |
Nemours Center for Childhood Cancer Research |
I Care I Cure |
131 I-MIBG Imaging and Therapy for Neuroblastoma: Infrastructure Proposal |
University of California San Francisco |
I Care I Cure |